Scrip
Pfizer and UCL to develop stem-cell therapies for macular degeneration
27 April 2009
Sita Shah
Please Login to read the full article.
27 April 2009
Sita Shah
sita.shah@informa.com
Pfizer is to provide funding to University College London (UCL) to develop new stem-cell treatments for age-related macular degeneration (AMD) and other retinal diseases.
The agreement will strengthen Pfizer's position in regenerative medicine, following the launch of its regenerative medicines...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- GE Healthcare aims to end unpredictability in early drug research
- Face-to-Face: Allon targets tau pathology with lead drug davunetide
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
